Inotiv Inc(NOTV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -2.48 | Insider Own | 8.64% | Shs Outstand | 34.9M | Perf Week | - |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | -4.29% | Shs Float | 32.3M | Perf Month | -69.15% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | 14% | Short Float | 7.81% | Perf Quarter | -78.75% |
| Income | - | P/S | 0.01 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.13 | Perf Half Y | -88.64% |
| Sales | 0.51B | P/B | 0.04 | EPS next 5Y | - | ROA | - | Short Interest | 2.52M | Perf YTD | -85.79% |
| Book/sh | 2.21 | P/C | - | EPS past 3/5Y | 46.54% - | ROE | - | 52W High | -97.29% ($2.95) | Perf Year | -97.19% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | -2.15% - | ROIC | - | 52W Low | 2.83% ($0.08) | Perf 3Y | -98.53% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 20.77% | Gross Margin | - | Volatility(W/M) | 74.35% 29.71% | Perf 5Y | -99.72% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | 5.61% | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | -92.01% |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 31.66 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | -5.4% | SMA20 | -65.09% ($0.23) | Beta | 3.92 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | 2026/2/9 | SMA50 | -69.45% ($0.26) | Rel Volume | 0 | Prev Close | $0.08 |
| Employees | 1945 | LT Debt/Eq | - | EPS/Sales Surpr. | -30.09% -0.02% | SMA200 | -88.9% ($0.72) | Avg Volume(3M) | 19.48M | Price | $0.08 |
| IPO | 1997/11/25 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
Based in Indiana, USA, this is a non-clinical CRO (Contract Research Organization) specializing in research animal models. The company offers Discovery and Safety Assessment (DSA) services for the early stages of drug development, while also running a Research Models & Services (RMS) segment that supplies a wide range of laboratory animals—including mice, rabbits, and non-human primates—to pharmaceutical, biotech, and academic clients.
Over the past 1 year, on the lower side
97% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $1. Peers typically go for $432.
Tap to view numbers
Not enough quarters to judge yet
Only 1 quarter(s) reported, so no grade yet.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.7%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 14.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #44 of 45 in the industry
Based on market cap of $3M.
FAQ
What kind of company is NOTV?
NOTV belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of NOTV?
The market cap of NOTV is approximately $3M, ranking 5,805 within its sector.
What is the 52-week high and low for NOTV?
NOTV has recorded a 52-week high of $2.95 and a low of $0.08.
